A Cure for Type 1 Diabetes? For One Man, It Seems to Have Worked.news2021-11-27T17:41:57+00:00November 27th, 2021|The New York Times|
Biolinq Raises $100 Million, Unveils Micro-Sensing Technology in the Skinnews2021-11-02T15:19:51+00:00November 2nd, 2021|Medical Device News Magazine|
DreaMed Launches its FDA-Cleared Diabetes Management Platform with a Leading U.S. Children’s Hospitalnews2021-10-20T18:01:36+00:00October 20th, 2021|Medical Device News Magazine|
